Xavier Thuru
72
%
Libre accès
47
Documents
Affiliations actuelles
- Centre de Recherche Jean-Pierre AUBERT Neurosciences et Cancer - U837 (JPArc)
- Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers = Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277 (CANTHER)
Identifiants chercheurs
Présentation
Publications
14
7
7
5
4
3
2
2
1
1
1
7
6
4
4
4
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
1
1
1
32
20
10
3
2
1
Publications
Induction of mu opioid and cannabinoid receptors by probiotics: A new mechanism of regulation of visceral pain perception5. Annual Advances in the Inflammatory Bowel Diseases, Dec 2006, Miami (Florida), United States. 13 (Supplement 5), pp.652-653, 2007, Abstracts from the 2006 CCFA National Research and Clinical Conference, 5th Annual Advances in the Inflammatory Bowel Diseases, Dec. 1‐3, 2006, Miami, FL. ⟨10.1097/00054725-200705001-00035⟩ |
NOVEL PYRAZOLE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORSFrance, Patent n° : EP23306103. 2023 |
|
NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORSFrance, Patent n° : WO2021009384. 2021 |
|
NOVEL PYRAZOLONE DERIVATIVES AS PD-1/PD-L1 INTERACTION INHIBITORSFrance, Patent n° : WO2021009384 (A1). 2021 |
Chargement...
Chargement...